FDA pushes development of abuse-deterrent opioid drugs
Thursday, March 24, 2016 - 14:10
in Mathematics & Economics
Stephen FellerBETHESDA, D.C., March 24 (UPI) -- The FDA has asked pharmaceutical companies to work together on abuse-deterrent generic versions of their opioid-based painkillers.